TECHNICAL,
SERVICE & CARE
TECHNICAL,
SERVICE & CARE
72
73
Technical Information
Federal Communications Commission (FCC) Certified Device
Technical InformationFederal Communications Commission
(FCC) Certified Device
This equipment has been tested and found to meet the
limits for a Class B digital device, pursuant to part 15
of the FCC Rules. These limits are designed to provide
reasonable protection against harmful interference in
a residential installation. This equipment generates,
uses and can radiate radio frequency energy and,
if not installed and used in accordance with the
instructions, may cause harmful interference to radio
communications. However, there is no guarantee that
interference will not occur in a particular installation.
If this equipment does cause harmful interference to
radio or television reception, which can be determined
by turning the equipment off and on, the user is
encouraged to try to correct the interference by one or
more of the following measures:
• Reorient or relocate the receiving antenna.
• Increase the separation between the equipment
and receiver.
This portable transmitter with its antenna complies
with FCC/IC RF exposure limits for general population/
uncontrolled exposure.
If you have questions, please contact Customer
Service. See the back cover for contact information.
Within
± 5 mg/dL
Within
± 10 mg/dL
Within
± 15 mg/dL
8 of 8
(100%)
8 of 8
(100%)
8 of 8
(100%)
Accuracy
The Contour
®
next LINK wireless blood glucose
monitoring system was tested by 110 lay users using
capillary blood samples and three Contour
®
next
test strip lots. The results were compared to the
YSI
®
Glucose Analyzer laboratory reference method,
traceable to the CDC hexokinase method. The tables
below show how well the two methods compare.
Table 1 — System accuracy results in lay users for
Contour next LInK meter using Contour next
test strips at glucose concentration < 75 mg/dL
Table 2 — System accuracy results in lay users for
Contour next LInK meter using Contour next
test strips at glucose concentration ≥ 75 mg/dL
Within
± 5%
Within
± 10%
Within
± 15%
Within
± 20%
82 of 102
(80.4%)
101 of 102
(99.0%)
101 of 102
(99.0%)
102 of 102
(100%)
WARNING (Part 15.21)
Changes or modifications not expressly
approved by the party responsible for
compliance could void the user’s authority to
operate the equipment.
To Next Page
Loading...
Need help?
General
